ChengDa Pharmaceuticals Co. Ltd. (301201) — Net Asset Quality Index
ChengDa Pharmaceuticals Co. Ltd. (301201) has a Net Asset Quality Index of 89.6% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.41 Billion minus total liabilities of CN¥249.97 Million yields net assets of CN¥2.16 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 301201 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
ChengDa Pharmaceuticals Co. Ltd. Net Asset Quality Index Over Time (2019–2024)
This chart shows how ChengDa Pharmaceuticals Co. Ltd.'s Net Asset Quality Index has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the index stands at 89.6%, representing net assets of CN¥2.16 Billion against total assets of CN¥2.41 Billion CNY. See ChengDa Pharmaceuticals Co. Ltd. (301201) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for ChengDa Pharmaceuticals Co. Ltd. (2019–2024)
The table below presents the year-by-year Net Asset Quality Index for ChengDa Pharmaceuticals Co. Ltd. from 2019 to 2024, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 301201 company net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 88.1% | CN¥2.15 Billion | CN¥2.44 Billion | CN¥290.77 Million | ▼ -4.7 pp |
| 2023 | 92.8% | CN¥2.28 Billion | CN¥2.46 Billion | CN¥176.40 Million | ▼ -2.6 pp |
| 2022 | 95.4% | CN¥2.22 Billion | CN¥2.32 Billion | CN¥105.81 Million | ▲ +17.9 pp |
| 2021 | 77.6% | CN¥529.93 Million | CN¥683.23 Million | CN¥153.30 Million | ▼ -8.3 pp |
| 2020 | 85.9% | CN¥458.91 Million | CN¥534.21 Million | CN¥75.30 Million | ▲ +20.5 pp |
| 2019 | 65.4% | CN¥357.35 Million | CN¥546.56 Million | CN¥189.21 Million | — |